Clinical Characteristics | Number of patients (%) | Mean dose (Gy) ± SD | Max | Min |
---|---|---|---|---|
Tumor Type | ||||
H Lymphoma | 10 (52.6) | - | - | - |
NH Lymphoma | 1 (5.3) | - | - | - |
Nasopharyngeal carcinoma | 2 (10.5) | - | - | - |
Oral cavity carcinoma | 1 (5.3) | - | - | - |
Oropharyngeal carcinoma | 1 (5.3) | - | - | - |
Laryngeal carcinoma | 2 (10.5) | - | - | - |
Breast carcinoma | 2 (10.5) | - | - | - |
Dose RT to the neck | 19 | 41.2 ± 15.6 | 70 | 25.2 |
Female | 9 (47.4) | 44.7 ± 13.2 | 30 | 60 |
Male | 10 (52.6) | 38.1 ± 15.7 | 70 | 25.2 |
≤ 52 years | 11 (58.0) | 31.2 ± 8.8 | 25.2 | 56 |
≥ 53 years | 8 (42.0) | 55.0 ± 12.2 | 30 | 70 |